Dr. Ankit Ajay Thakker has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Ankit Thakker, Promoter, Whole Time Director & CEO of Jupiter Life Line Hospitals, has filed the annual Regulation 31(4) declaration on behalf of all promoters, promoter group, and persons acting in concert. He confirms that no encumbrance (pledge, lien, or charge) was created, directly or indirectly, on the company's shares during the financial year ended March 31, 2025. The attached list shows the total promoter group holding stands at 2,68,25,623 shares, or 40.91% of the company. Top individual holders include Ajay Pratap Thakker (20.74%), Western Medical Solutions LLP (8.70%), and Ankit Ajay Thakker (6.67%).
This is a routine annual compliance filing and is neutral for shareholders. It reassures investors that promoters have not pledged or encumbered any additional shares during the year, meaning no new financial pressure or risk of forced selling has been introduced from the promoter side.